Ciprofloxacin-OVA
Ciprofloxacin-OVA is a conjugate of Ciprofloxacin (HY-B0356) and Ovalbumin (OVA) . By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].
Product Specifications
UNSPSC
12352100
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Inflammation/Immunology
Smiles
[Ciprofloxacin-OVA]
References & Citations
[1]Tsai WC, et, al. Ciprofloxacin-mediated cell proliferation inhibition and G2/M cell cycle arrest in rat tendon cells. Arthritis Rheum. 2008 Jun;58 (6) :1657-63.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6300239-01 0.2 mL
FSTL1, CT (FSTL1, FRP, Follistatin-related protein 1, Follistatin-like protein 1) (Azide free) (HRP)
Ask
View Details 
MBS6300239-02 5x 0.2 mL
FSTL1, CT (FSTL1, FRP, Follistatin-related protein 1, Follistatin-like protein 1) (Azide free) (HRP)
Ask
View Details 
MBS1241182-01 0.02 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 5b Protein hfq (hfq)
Ask
View Details MBS1241182-02 0.1 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 5b Protein hfq (hfq)
Ask
View Details